| Dr Matthew P Walters, MD | |
|
2845 Greenbrier Road, Green Bay, WI 54311 | |
| (920) 288-4746 | |
| (920) 288-4737 |
| Full Name | Dr Matthew P Walters |
|---|---|
| Gender | Male |
| Speciality | Pathology |
| Experience | 18 Years |
| Location | 2845 Greenbrier Road, Green Bay, Wisconsin |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497835862 | NPI | - | NPPES |
| ENROLLED | Medicaid | MN |
| Facility Name | Location | Facility Type |
|---|---|---|
| Aurora Baycare Medical Ctr | Green bay, WI | Hospital |
| Aurora Medical Ctr Manitowoc County | Two rivers, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Great Lakes Pathologists Sc | 7315850682 | 60 |
News Archive
Measuring kidney function in children can be expensive, time-consuming for clinicians, and tedious for children, who may be exposed to radioactivity and subjected to a large number of blood draws.
WHITEHOUSE STATION known as MSD outside the United States and Canada, and Luminex Corporation have signed a collaboration and license agreement to develop a companion diagnostic device that will be evaluated to help screen patients for recruitment into Merck's clinical development program for MK-8931, a novel oral beta amyloid precursor protein site cleaving enzyme (BACE) inhibitor and Merck's lead investigational candidate for Alzheimer's disease (AD).
Today, the International and American Associations for Dental Research (IADR/AADR) published a Discovery! article titled "10 Years of a National Oral Health Policy in Brazil: Innovation, Boldness and Numerous Challenges."
Cornerstone Pharmaceuticals and Wake Forest Baptist Medical Center today announced key findings from a Phase I clinical trial of Cornerstone's first-in-class cancer metabolism inhibitor drug, CPI-613 in Acute Myeloid Leukemia.
› Verified 5 days ago
| Entity Name | Great Lakes Pathologists Sc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689695934 PECOS PAC ID: 7315850682 Enrollment ID: O20031112000106 |
News Archive
Measuring kidney function in children can be expensive, time-consuming for clinicians, and tedious for children, who may be exposed to radioactivity and subjected to a large number of blood draws.
WHITEHOUSE STATION known as MSD outside the United States and Canada, and Luminex Corporation have signed a collaboration and license agreement to develop a companion diagnostic device that will be evaluated to help screen patients for recruitment into Merck's clinical development program for MK-8931, a novel oral beta amyloid precursor protein site cleaving enzyme (BACE) inhibitor and Merck's lead investigational candidate for Alzheimer's disease (AD).
Today, the International and American Associations for Dental Research (IADR/AADR) published a Discovery! article titled "10 Years of a National Oral Health Policy in Brazil: Innovation, Boldness and Numerous Challenges."
Cornerstone Pharmaceuticals and Wake Forest Baptist Medical Center today announced key findings from a Phase I clinical trial of Cornerstone's first-in-class cancer metabolism inhibitor drug, CPI-613 in Acute Myeloid Leukemia.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Matthew P Walters, MD 2845 Greenbrier Road, Green Bay, WI 54311 Ph: (920) 288-4746 | Dr Matthew P Walters, MD 2845 Greenbrier Road, Green Bay, WI 54311 Ph: (920) 288-4746 |
News Archive
Measuring kidney function in children can be expensive, time-consuming for clinicians, and tedious for children, who may be exposed to radioactivity and subjected to a large number of blood draws.
WHITEHOUSE STATION known as MSD outside the United States and Canada, and Luminex Corporation have signed a collaboration and license agreement to develop a companion diagnostic device that will be evaluated to help screen patients for recruitment into Merck's clinical development program for MK-8931, a novel oral beta amyloid precursor protein site cleaving enzyme (BACE) inhibitor and Merck's lead investigational candidate for Alzheimer's disease (AD).
Today, the International and American Associations for Dental Research (IADR/AADR) published a Discovery! article titled "10 Years of a National Oral Health Policy in Brazil: Innovation, Boldness and Numerous Challenges."
Cornerstone Pharmaceuticals and Wake Forest Baptist Medical Center today announced key findings from a Phase I clinical trial of Cornerstone's first-in-class cancer metabolism inhibitor drug, CPI-613 in Acute Myeloid Leukemia.
› Verified 5 days ago
Matthew L Snyder, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 2845 Greenbrier Road, Green Bay, WI 54311 Phone: 920-288-4740 Fax: 920-288-4737 | |
Dr. Charles F Dais Ii, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 835 S Van Buren St, Green Bay, WI 54301 Phone: 920-433-8047 | |
Oliver Graf, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 1726 Shawano Ave, Green Bay, WI 54303 Phone: 920-498-4200 | |
Nathanial I Kieler, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 744 S Webster Ave, Green Bay, WI 54301 Phone: 920-433-3653 | |
Robert Joseph Murphy, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 1726 Shawano Ave, Green Bay, WI 54303 Phone: 920-496-4700 Fax: 920-884-3566 | |
Dr. Thomas S Fredeen, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 744 S Webster Ave, Green Bay, WI 54301 Phone: 920-433-3653 | |
Omeed Hafez, Pathology Medicare: Medicare Enrolled Practice Location: 744 S Webster Ave, Green Bay, WI 54301 Phone: 920-433-3653 |